Daxor Net Income 2012-2011 | DXR

Daxor net income from 2012 to 2011. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
Unlock Macrotrends Premium
40 years of data
Faster, ad-free pages
Unlimited data exports
Full-width charts
Daxor Annual Net Income
(Millions of US $)
2011 $-7
Daxor Quarterly Net Income
(Millions of US $)
2011-12-31 $-1
2011-09-30 $-4
2011-06-30 $0
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.048B $0.000B
Daxor Corporation is a medical device manufacturing corporation with additional biotech services.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $29.514B 13.37
Quest Diagnostics (DGX) United States $21.197B 19.44
Elanco Animal Health (ELAN) United States $11.500B 24.35
Encompass Health (EHC) United States $10.662B 19.64
DaVita (DVA) United States $10.023B 13.82
Chemed (CHE) United States $5.639B 19.57
Option Care Health (OPCH) United States $4.553B 18.71
RadNet (RDNT) United States $4.302B 142.13
LifeStance Health (LFST) United States $2.495B 320.00
Addus HomeCare (ADUS) United States $1.719B 16.61
Astrana Health (ASTH) United States $1.536B 31.40
Aveanna Healthcare Holdings (AVAH) United States $1.353B 12.20
U.S Physical Therapy (USPH) United States $1.157B 29.19
Pennant (PNTG) United States $1.072B 31.31
MEDIROM Healthcare Technologies (MRM) Japan $0.032B 0.00
Psychemedics (PMD) United States $0.000B 0.00